StockWatch
·
Pharmaceuticals
Corporate Governance4 Nov 2026, 08:42 pm

Transchem Ltd: Monitoring Agency Report for Q3 2026

AI Summary

Transchem Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026. The report, issued by Acuite Ratings & Research Limited, confirms that the utilization of proceeds from the Preferential Issue of Warrants is in line with the disclosed objects. No deviation was observed. The report was reviewed by the Audit Committee and taken on record by the Board of Directors on November 04, 2026. The company raised ₹461.25 Cr through the preferential issue of warrants, with the balance 75% receivable upon exercise by December 2027. No material facts affecting investor decision-making were highlighted.

Key Highlights

  • Monitoring Agency Report confirms no deviation in utilization of preferential issue proceeds.
  • Report covers utilization for the quarter ended September 30, 2026.
  • Proceeds were raised via Preferential Issue of Warrants.
  • Report reviewed by Audit Committee and Board of Directors.
  • No material unfavorable events affecting project viability were noted.